New AI method to pick up arthritis, lupus early in high-risk patients

0
6
New AI method to pick up arthritis, lupus early in high-risk patients
Advetisment

New Delhi, Jan 8 (IANS) Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and lupus especially in high-risk patients, leading to better outcomes, finds a study.

In people with autoimmune diseases, the immune system mistakenly attacks their body’s healthy cells and tissues. Some well-known diseases include type 1 diabetes, multiple sclerosis, lupus, and rheumatoid arthritis.

Early diagnosis is critical and may improve treatment and better disease management, said the team led by researchers from the Penn State College of Medicine.

Using machine learning, a type of AI, the team developed a new method that could predict the progression of autoimmune disease among people with preclinical symptoms.

These diseases often include a preclinical stage before diagnosis that’s characterised by mild symptoms or certain antibodies in the blood.

The method dubbed Genetic Progression Score or GPS, could predict the progression from preclinical to disease stages.

In the study, the team used GPS to analyse real-world data to predict the progression of rheumatoid arthritis and lupus.

Compared to existing models, this methodology was found between 25 and 1,000 per cent more accurate in determining mild symptoms that would move to advanced disease stage, the findings showed.

“By targeting a more relevant population — people with a family history or who are experiencing early symptoms — we can use machine learning to identify patients with the highest risk for disease,” said Dajiang Liu, Professor, at the Penn State College of Medicine. Liu noted that this can also help “identify suitable therapeutics that may be able to slow down the progression of the disease”.

Accurate prediction of disease progression using GPS can enable early interventions, targeted monitoring, and personalised treatment decisions, leading to improved patient outcomes, Liu said.

–IANS

rvt/

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

Advertisment